CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 60 enrolled
Drug / intervention
creatine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01257581
NCT01257581Phase 2Completed
CompareCT.gov

Phase 2 Selection Trial of High Dosage Creatine and Two Dosages of Tamoxifen in Amyotrophic Lateral Sclerosis (ALS)

Nazem Atassi·interventional·Posted Dec 9, 2010·Updated Dec 4, 2014

In Brief

A Phase 2 clinical trial evaluating creatine and tamoxifen for Amyotrophic Lateral Sclerosis. Completed, enrolled 60 participants across 9 sites.

Detailed Summary

The purpose of the study is to evaluate the safety and efficacy of high dose creatine and two dosages of tamoxifen treatment in amyotrophic lateral sclerosis (ALS).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAmyotrophic Lateral Sclerosis
CountriesUnited States
CollaboratorsALS Therapy Alliance, State University of New York - Upstate Medical University

Timeline

Phase 2CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedDec 9, 2010
Enrollment StartMar 1, 2011
Primary CompletionDec 1, 2012
Study CompletionFeb 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 15.6 years ago

Interventions

creatinedrug

creatine monohydrate powder

tamoxifendrug

Tamoxifen citrate capsules